Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia.
Mishchenko DV, Neganova ME, Klimanova EN, Sashenkova TE, Klochkov SG, Shevtsova EF, Vystorop IV, Tarasov VV, Chubarev VN, Samsonova AN, Ashraf GM, Barreto G, Yarla NS, Aliev G. Mishchenko DV, et al. Among authors: aliev g. Curr Cancer Drug Targets. 2018;18(4):365-371. doi: 10.2174/1568009617666170623104030. Curr Cancer Drug Targets. 2018. PMID: 28669342
New Spirocyclic Hydroxamic Acids as Effective Antiproliferative Agents.
Neganova ME, Klochkov SG, Aleksandrova YR, Osipov VN, Avdeev DV, Pukhov SA, Gromyko AV, Aliev G. Neganova ME, et al. Among authors: aliev g. Anticancer Agents Med Chem. 2021;21(5):597-610. doi: 10.2174/1871520620666200527132420. Anticancer Agents Med Chem. 2021. PMID: 32459611
New Therapeutic Property of Dimebon as a Neuroprotective Agent.
Ustyugov A, Shevtsova E, Ashraf GM, Tarasov VV, Bachurin SO, Aliev G. Ustyugov A, et al. Among authors: aliev g. Curr Med Chem. 2018;25(39):5315-5326. doi: 10.2174/0929867323666160804122746. Curr Med Chem. 2018. PMID: 27494393 Review.
Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach.
Neganova ME, Klochkov SG, Petrova LN, Shevtsova EF, Afanasieva SV, Chudinova ES, Fisenko VP, Bachurin SO, Barreto GE, Aliev G. Neganova ME, et al. Among authors: aliev g. CNS Neurol Disord Drug Targets. 2017;16(3):351-355. doi: 10.2174/1871527315666161107090525. CNS Neurol Disord Drug Targets. 2017. PMID: 27823572
Gliomas: New Perspectives in Diagnosis, Treatment and Prognosis.
Ghotme KA, Barreto GE, Echeverria V, Gonzalez J, Bustos RH, Sanchez M, Leszek J, Yarla NS, Gomez RM, Tarasov VV, Ashraf GM, Aliev G. Ghotme KA, et al. Among authors: aliev g. Curr Top Med Chem. 2017;17(12):1438-1447. doi: 10.2174/1568026617666170103162639. Curr Top Med Chem. 2017. PMID: 28049399 Review.
Anthocyanins: Multi-Target Agents for Prevention and Therapy of Chronic Diseases.
Putta S, Yarla NS, Peluso I, Tiwari DK, Reddy GV, Giri PV, Kumar N, Malla R, Rachel V, Bramhachari PV, Reddy D RS, Bade R, Mannarapu M, Barreto GE, Lu DY, Tarasov VV, Chubarev VN, Ribeiro FF, Scotti L, Scotti MT, Kamal MA, Ashraf GM, Aliev G, Perry G, Sarker SD, Rao CV, Bishayee A. Putta S, et al. Among authors: aliev g. Curr Pharm Des. 2017;23(41):6321-6346. doi: 10.2174/1381612823666170519151801. Curr Pharm Des. 2017. PMID: 28741457 Review.
Pharmacological Aspects of Neuro-Immune Interactions.
Tarasov VV, Kudryashov NV, Chubarev VN, Kalinina TS, Barreto GE, Ashraf GM, Aliev G. Tarasov VV, et al. Among authors: aliev g. Curr Pharm Des. 2018;24(1):15-21. doi: 10.2174/1381612823666170829135115. Curr Pharm Des. 2018. PMID: 28875850 Review.
306 results